July 4, 2014
The project MYO-MRI aims to develop applications of magnetic resonance imaging and spectroscopy techniques in neuromuscular disease in order to develop collaborations on outcome measures and pattern recognition for diagnostics and therapy development. It was approved in June 2013 as a COST Action and formally launched on 2 December 2013.
This project will roll out the use of magnetic resonance techniques by sharing expertise and data, validating protocols across platforms and by exploring the potential of magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) as a diagnostic tool and as a quantitative outcome measure in neuromuscular diseases clinical trials. Through standardizing the applications of MRI and MRS in neuromuscular diseases, the training of early stage researchers and the development of an online atlas of neuromuscular imaging, the project will enhance the knowledge and expertise of scientists and healthcare professionals and ultimately benefit patients with neuromuscular diseases.
A working Group meeting was held in Milan, Italy, on 16-18 May 2014 to discuss ways to improve diagnosis and to better understand muscle pathology. More than 50 researchers and scientists from across Europe and the US and from a range of disciplines met at this occasion.
Individuals from countries not yet represented, and with an interest in joining MYO-MRI, can contact Prof Volker Straub, MYO-MRI Chair, to discuss participation. Please direct your emails to Olav Veldhuizen: email@example.com